Arecor Therapeutics plc (AIM: AREC)
Health Care · Biotechnology · GB
£0.73
0.00% today · -13.7% 1Y
Arecor Therapeutics plc (AIM: AREC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $36.22M.
Over the last twelve months the share price has lost 13.7%, trading between 0.55 and 0.95.
Tweenvest scores Arecor Therapeutics plc across four factors: quality 36/100, value 42/100, growth 60/100. Its strongest factor is growth.
AREC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $36.22M
- Revenue (TTM)
- $1.18M
- P/E
- —
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 0.08
- 52-week high
- £0.95
- 52-week low
- £0.55
- Avg volume (3M)
- —
- Shares outstanding
- 37.76M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TMS Co., Ltd.TSE: 4891 | $36.48M | ¥126.00 | -5.97% |
| Genenta Science S.p.A.NasdaqCM: GNTA | $36.40M | $0.76 | -3.28% |
| Enimmune CorporationTPEX: 6564 | $36.23M | NT$16.00 | -3.61% |
| AIxCrypto Holdings, Inc.NasdaqCM: AIXC | $36.22M | $1.79 | +29.71% |
| BriaCell Therapeutics Corp.TSX: BCT | $35.09M | CA$5.69 | -1.04% |
| Aligos Therapeutics, Inc.NasdaqCM: ALGS | $34.59M | $5.32 | -3.97% |
| Organoidsciences Ltd.KOSDAQ: A476040 | $34.52M | ₩7,060.00 | +4.28% |
| Elutia Inc.NasdaqCM: ELUT | $34.49M | $0.82 | +5.32% |
Figures last refreshed Oct 4, 2026.